Qualified institutional placements (QIPs) witnessed a resilient growth in July so far, led by State Bank of India’s (SBI) ...

SBIs RS25,000 crore QIP, oversubscribed 3×, has pushed India’s QIP fundraising to a 5-year high, reflecting strong ...

The Indian stock market declined for the second day on July 18, with the Sensex down 502 points to 81,757.73. Unimpressive ...

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo Nordisk A/S’ Novolog (insulin aspart), a ...

Indian equity indices continued their downward trend for the second straight session on 18 July , with Nifty dropping below ...

Little surprise then that Citi was top of Dealogic’s Asia Pacific ex-Japan G3 DCM revenue league table in 2024, with $77 ...

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

Forbes’ 2025 list ranks Nykaa’s Falguni Nayar and Biocon’s Kiran Mazumdar-Shaw among the 50 wealthiest self-made women in the ...

State Bank of India (SBI), the largest lender in the country, has launched a share sale to institutional investors to raise ...